STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapy.
- Resource Type
- Article
- Source
Journal of Chemotherapy (Taylor & Francis Ltd) . Feb2024, Vol. 36 Issue 1, p61-71. 11p.- Subject
- Language
- ISSN
- 1120-009X